Share on LinkedInShare on LinkedIn

ARTICLE · 06 JANUARY 2021

Spotlight On Upcoming Oral Arguments – January 2021

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...

View firm profile
Explore more from Finnegan, Henderson, Farabow, Garrett & Dunner LLP

The following telephone arguments will be available to the public live. Access information will be available by 9 AM ET each day of argument at: http://www.cafc.uscourts.gov/public-access-arguments.

United StatesIntellectual Property

The following telephone arguments will be available to the public live. Access information will be available by 9 AM ET each day of argument at: http://www.cafc.uscourts.gov/public-access-arguments.

Monday, January 4, 2021

Mylan Laboratories Ltd. v. Sanofi Mature IP, No. 20-1302

Mylan petitioned for inter partes review ("IPR") against U.S. Patent No. 8,927,592 (the "'592 patent") held by Sanofi. The Patent Trial and Appeal Board ("PTAB") held that all of the challenged claims were unpatentable as obvious and denied Sanofi's motion to amend several claims, including amendments to the preamble of a method claim to include "increasing survival" as an intentional purpose. Sanofi appealed to the Federal Circuit, which held that the preamble with the intentional purpose was limiting and remanded the case to the PTAB for reconsidering its denial of Sanofi's motion to amend. On remand, the PTAB granted the motion and concluded that the proposed amended method claim

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from